RENUVA® Filler Treatment (Injection)
This video is an Introduction to Renuva.
Other related Renuva videos:
- Renuva Facial Treatment - [ Ссылка ]
- Renuva Hand Treatment - [ Ссылка ]
Renuva is a no down-time, off-the shelf filler treatment to fix those small aesthetic defects that have always bothered you, such as liposuction irregularities, cellulite dimples, or loss of volume in your hands, cheeks or temples. You get the smooth contours and added volume you want to look and feel your best, without the pain and expense of liposuction.
CONTACT DR. PAUL
Call now at 619.588.9355 or Book Session at [ Ссылка ]
KEY ADVANTAGES
- No down-time – you can immediately return to normal activities.
- Fast procedure – about 10 to 30 minutes (estimated).
- No need for liposuction.
- Uses your own natural body processes.
- Lasts 5 years (estimated).
ABOUT
Renuva is an in-office, injectable tissue treatment that allows your own body to correct small volume soft tissue defects. Your body reacts naturally to Renuva to fix your small aesthetic defects and improve your skin tone and texture.
Unlike anything else available on the market today, Renuva utilizes your own body to generate fat where the product is injected. It is designed to allow your own body to grow fat into the space that the injection occupies.
Renuva is an injectable allograft adipose matrix, meaning it comes from processed, donated human adipose (fat) tissue. It contains key proteins and growth factors relevant to the creation of new fat tissue to help restore volume in areas where some native fat already exists.
Allograft tissue comes from donors and is tested and screened in accordance with the U.S. Food and Drug Administration’s (FDA) requirements for donor tissue. Advanced processing and testing provide assurance that you are receiving healthy, safe tissue. MTF Biologics (the manufacturer) donor selection process, designed by medical experts, ensures the highest quality and safety. MTF Biologics has grown to become the largest accredited tissue bank in the world, having distributed more than 8 million allografts.
